Xolair approved for Chronic Urticaria (Hives)
Xolair (omalizumab), which is an anti-IgE antibody used for allergic asthma, has been approved for chronic hives. This will keep a lot of patients from having to use low dose transplant medications for severe hives.
Posted on March 24, 2014 Leave a comment
This entry was posted in My Medical Blog and tagged allergies, allergy partners, asthma, chronic urticaria, derek damin, Dr. Damin, Dr. Damin Louisville, hives, itching, Omalizumab, urticaria, Xolair. Bookmark the permalink.
Dr. Derek Damin